Clinical Trials Directory

Trials / Completed

CompletedNCT00832156

Application of Cultured Autologous Keratinocytes for Burn Wound Healing

Application of Cultured Autologous Keratinocytes in Combination With a Meshed Split Skin Autograft for Burn Wound Healing

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Association of Dutch Burn Centres · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In this study the treatment of full thickness burn wounds with cultured autologous keratinocytes in combination with meshed split skin autograft versus meshed split skin graft alone will be compared. It is expected that the application of cultured autologous keratinocytes in combination with a meshed split skin autograft will improve wound healing and scar formation.

Detailed description

The standard treatment for extensive burn wounds is transplantation with meshed split skin graft. Disadvantages of this treatment are that healing of large full thickness burn wounds is still accompanied by scar formation. Even standard treatment, transplantation with a (meshed) split skin autograft, does not result in satisfactory functional and cosmetic appearance of the healed wound. Due to limited available donor sites meshes needs to be enlarged. Bigger enlargements of meshes give more scarring and mesh pattern are still visible in scars, probably because wound closure still needs several weeks. Application of cultured autologous keratinocytes may enhance wound closure and improve outcome of healing. Primary objective: Does the application of cultured autologous keratinocytes on deep burn wounds accelerate wound closure Secondary objectives: Does the application of cultured autologous keratinocytes on deep burn wounds improve scar quality with respect to scar elasticity, colour/pigmentation and/or smoothness after 3 and 12 months.

Conditions

Interventions

TypeNameDescription
BIOLOGICALCultured autologous keratinocytesThe experimental wound site will be covered with cultured keratinocytes on a collagen/elastin carrier after the application of a meshed split skin autograft. The control wound site will be covered with a meshed split skin autograft alone.

Timeline

Start date
2008-06-01
Primary completion
2012-09-01
Completion
2013-09-01
First posted
2009-01-29
Last updated
2020-02-17

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00832156. Inclusion in this directory is not an endorsement.